{
    "doi": "https://doi.org/10.1182/blood.V112.11.555.555",
    "article_title": "Older Age Is An Independent Risk Factor in AML ",
    "article_date": "November 16, 2008",
    "session_type": "Acute Myeloid Leukemia - Therapy, excluding Transplantation",
    "abstract_text": "Among the entire patients with AML the majority is 60 years of age or older. In present German multicenter AML Cooperative Group (AMLCG) trial the proportion of these older patients amounts to 54% of all 2734 patients enrolled and receiving intensive chemotherapy. While older age AML is increasingly recognized as a main challenge the therapeutic outcome unlike that in younger patients has remained constantly poor. Thus, the patients of \u2265 60y show an overall survival (OS) of 13% and a relapse rate (RR) of 82% at 5y versus 40% and 52% in younger patients. Age related differences in treatment and in risk profiles are commonly used to explain the differences in outcome. In the AMLCG 99 trial including 2734 patients 16 to 85 (median 61) years of age we investigated factors determining the disease biology and outcome. For induction treatment patients received standard dose TAD and high-dose AraC 3 (age < 60y) and 1 (\u2265 60y) g/m\u00b2 \u00d7 6/mitoxantrone (HAM) or randomly HAM-HAM, for consolidation TAD, and for maintenance monthly reduced TAD randomized (in patients < 60y) against autologous SCT. When compared with patients younger than 60y older patients had more frequent secondary AML (29% vs 17%, p< 0.0001), unfavorable cytogenetics (29% vs 23%, p= 0.0004), less frequent favorable cytogenetics (4% vs 12%, p< 0.0001), and NPM1mut/FLT3-ITDneg status (26% vs 34%, p< 0.009) in those with normal karyotype, and overall even lower median WBC (7.360 vs 12.600/\u03bcl, p< 0.0001) and LDH (340 vs 413 U/l, p< 0.0001). A multivariate analysis identified independent risk factors determining therapeutic endpoints such as CR rate, OS, RR, and RFS. With similar results across all endpoints, risk factors for OS were age \u2265 60y (HR 1.96, 95% CI 1.75\u20132.17), AML secondary to MDS or cytotoxic treatment (1.28, 1.14\u20131.45), unfavorable karyotype (2.17, 1.92\u2013 2.44), WBC > 20\u00d710\u00b3/\u03bcl (1.15, 1.02\u2013 1.30), LDH > 700U/L (1.32, 1.15\u2013 1.52), favorable karyotype (0.49, 0.38\u2013 0.63) and female gender (0.90, 0.81\u2013 0.99). In the 891 patients with normal karyotype and complete mutation status risk factors for OS were age \u2265 60y (2.00, 1.64\u2013 2.44), and NPM1mut/FLT3-ITDneg (0.39, 0.30\u2013 0.49). Risk factors for RR overall were age \u2265 60y (2.04, 1.75\u2013 2.38), unfavorable karyotype (2.08, 1.47\u2013 2.13), LDH (1.41, 1.16\u2013 1.72) and favorable karyotype (0.40, 0.29\u2013 0.56). In patients with normal karyotype and complete mutation status risk factors for RR were age \u2265 60y (2.00, 1.56\u2013 2.63), and NPM1mut/FLT3-ITDneg (0.32, 0.23\u2013 0.43). Testing the role of older age in favorable subgroups, the 198 patients with CBF leukemia show an OS at 5 years of 27.5 (95% CI 12.0\u2013 43.0) % in the older versus 69.4 (60.7\u2013 78.2) % in the younger age group, and a RR of 56.6 (35.7\u2013 77.3) % versus 25.0 (15.6\u2013 34.4) %. Comparatively, the 264 patients with a normal karyotype and NPM1mut/FLT3-ITDneg show an OS of 37.1 (26.6\u2013 47.5) % in the older versus 71.9 (63.4\u2013 80.4) % in the younger age group, and a RR of 61.0 (47.8\u2013 74.2) % versus 23.0 (14.0\u2013 32.0) %. There was no influence by randomized treatment variables on any therapeutic endpoint. Conclusion: Considering the prognostic spectrum of all major historic or genetic subgroups older age maintains its dominant role not explained by age related differences in risk profiles. Even within CBF leukemias and sole NPM1 mutation as the best prognostic categories older age predicts for markedly shorter OS and higher RR. Thus, understanding older age AML requires further genetic and epigenetic work.",
    "topics": [
        "chemotherapy regimen",
        "clinical trials cooperative groups",
        "cytogenetics",
        "epigenetics",
        "flt3 gene",
        "gender",
        "genetics",
        "karyotype determination procedure",
        "leukemia",
        "leukemia, secondary acute"
    ],
    "author_names": [
        "Thomas Buchner",
        "Wolfgang E. Berdel",
        "Claudia Haferlach",
        "Susanne Schnittger",
        "Torsten Haferlach, MD",
        "Hubert Serve",
        "Carsten Mu\u0308ller-Tidow",
        "Jan Braess",
        "Karsten Spiekermann",
        "Joachim Kienast",
        "Rolf Mesters",
        "Sarah Volpert",
        "Peter Staib",
        "Andreas Gru\u0308neisen",
        "Wolfgang Kern",
        "Albrecht Reichle",
        "Wolf-Dieter Ludwig",
        "Georg Maschmeyer",
        "Ludwig Balleisen",
        "Hartmut Eimermacher",
        "Carlo Aul",
        "Aristoteles Giagounidis",
        "Herbert Rasche",
        "Ruediger Hehlmann",
        "Eva Lengfelder",
        "Wolfgang Koepcke",
        "Utz O. Krug",
        "Maria Cristina Sauerland",
        "Achim Heinecke",
        "Bernhard Josef Woermann",
        "Wolfgang Hiddemann, MD"
    ],
    "author_dict_list": [
        {
            "author_name": "Thomas Buchner",
            "author_affiliations": [
                "Dept. of Internal Medicine, Hematology/Oncology, University of Mu\u0308nster, Mu\u0308nster, Germany"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Wolfgang E. Berdel",
            "author_affiliations": [
                "Department of Medicine, Hematology and Oncology, University of Mu\u0308nster, Mu\u0308nster, Germany"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Claudia Haferlach",
            "author_affiliations": [
                "MLL Munich Leukemia Laboratory GmbH, Munich, Germany"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Susanne Schnittger",
            "author_affiliations": [
                "MLL Munich Leukemia Laboratory GmbH, Munich, Germany"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Torsten Haferlach, MD",
            "author_affiliations": [
                "MLL Munich Leukemia Laboratory GmbH, Munich, Germany"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Hubert Serve",
            "author_affiliations": [
                "Dept. of Internal Medicine, University Hospital of Frankfurt, Frankfurt, Germany"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carsten Mu\u0308ller-Tidow",
            "author_affiliations": [
                "Dept. of Internal Medicine, Hematology/Oncology, University of Mu\u0308nster, Mu\u0308nster, Germany"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jan Braess",
            "author_affiliations": [
                "III. Dept. of Internal Medicine, University of Munich, Munich, Germany"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Karsten Spiekermann",
            "author_affiliations": [
                "III. Dept. of Internal Medicine, University of Munich, Munich, Germany"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Joachim Kienast",
            "author_affiliations": [
                "Dept. of Internal Medicine, Hematology/Oncology, University of Mu\u0308nster, Mu\u0308nster, Germany"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rolf Mesters",
            "author_affiliations": [
                "Dept. of Internal Medicine, Hematology/Oncology, University of Mu\u0308nster, Mu\u0308nster, Germany"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sarah Volpert",
            "author_affiliations": [
                "Dept. of Human Genetics, University of Mu\u0308nster, Mu\u0308nster, Germany"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Peter Staib",
            "author_affiliations": [
                "Dept. of Hematology/Oncology, St. Antonius Hospital, Eschweiler, Germany"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Andreas Gru\u0308neisen",
            "author_affiliations": [
                "Dept. of Hematology/Oncology, Vivantes Clinic Neuko\u0308lln, Berlin"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Wolfgang Kern",
            "author_affiliations": [
                "MLL Munich Leukemia Laboratory GmbH, Munich, Germany"
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Albrecht Reichle",
            "author_affiliations": [
                "Dept. of Hematology/Oncology, University of Regensburg, Regensburg, Germany"
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Wolf-Dieter Ludwig",
            "author_affiliations": [
                "Dept. of Hematology/Oncology, Robert-Roessle-Clinic, Charite, Berlin, Germany"
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Georg Maschmeyer",
            "author_affiliations": [
                "Dept. of Hematology/Oncology, Ernst-von-Bergmann Clinic, Potsdam, Germany"
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ludwig Balleisen",
            "author_affiliations": [
                "Dept. of Hematology/Oncology, Evangel. Hospital Hamm, Hamm, Germany"
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Hartmut Eimermacher",
            "author_affiliations": [
                "Dept. of Hematology/Oncology, KKH St. Marien Hospital, Hagen, Germany"
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carlo Aul",
            "author_affiliations": [
                "Medical Clinic II, St. Johannes Hospital, Duisburg, Germany"
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Aristoteles Giagounidis",
            "author_affiliations": [
                "Medical Clinic II, St. Johannes Hospital, Duisburg, Germany"
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Herbert Rasche",
            "author_affiliations": [
                "Dept. of Hematology/Oncology, Klinikum Bremen-Mitte, Bremen, Germany"
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ruediger Hehlmann",
            "author_affiliations": [
                "Dept. of Hematology/Oncology, University of Heidelberg, Mannheim, Germany"
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Eva Lengfelder",
            "author_affiliations": [
                "Dept. of Hematology/Oncology, University of Heidelberg, Mannheim, Germany"
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Wolfgang Koepcke",
            "author_affiliations": [
                "Dept. of Medical Informatics and Biomathematics, University of Mu\u0308nster, Mu\u0308nster, Germany"
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Utz O. Krug",
            "author_affiliations": [
                "Dept. of Internal Medicine, Hematology/Oncology, University of Mu\u0308nster, Mu\u0308nster, Germany"
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Cristina Sauerland",
            "author_affiliations": [
                "Dept. of Medical Informatics and Biomathematics, University of Mu\u0308nster, Mu\u0308nster, Germany"
            ],
            "author_rank": 28,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Achim Heinecke",
            "author_affiliations": [
                "Dept. of Medical Informatics and Biomathematics, University of Mu\u0308nster, Mu\u0308nster, Germany"
            ],
            "author_rank": 29,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Bernhard Josef Woermann",
            "author_affiliations": [
                "Stadtische Kliniken Braunschweig, Braunschweig, Germany"
            ],
            "author_rank": 30,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Wolfgang Hiddemann, MD",
            "author_affiliations": [
                "Department of Internal Medicine III, University of Munich- Hopsital Gro\u00dfhadern, Munich, Germany"
            ],
            "author_rank": 31,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-08T21:28:02",
    "is_scraped": "1"
}